Therefore, the inhibitors developed for the C467 residue of ASCT2 boast the advantages of high specificity and high potency, which can effectively avoid the loss of competitive inhibition by substrate analog inhibitors due to high substrate concentration
Pure Erythroid Leukemia Is Characterized By TP53 mutations, a Complex Karyotype with Chromosome 17 Abnormalities, and Adverse Risk Independent of Therapy Type
Personalized treatment plans are created for eligible patients when clinically appropriate
Because Dihexa is both orally bioavailable and capable of crossing the blood-brain barrier, it can reach the central nervous system through routes that are practical for clinical use
Reduced weight regain risk: Cagrilintide may help break the cycle of yo-yo dieting by curbing rebound hyperphagia (excessive hunger after dieting)
Short N, DiNardo C, Daver N, Nguyen D, Yilmaz M, Kadia T, Garcia-Manero G, Issa G, Huang X, Qiao W, Sasaki K, Montalban-Bravo G, Chien K, Borthakur G , Delumpa R, Milton A, Pierce S, Jabbour E, Konopleva M, Kantarjian H, Ravandi F